8-K 1 d8k.htm FORM 8-K Form 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):     January 11, 2005

 

Commission File No. 001-12392

 


 

NDCHealth Corporation

(Exact name of registrant as specified in its charter)

 

DELAWARE   58-0977458
(State or other jurisdiction of   (IRS Employer
incorporation)   Identification Number)

 

NDC Plaza, Atlanta, Georgia             30329-2010

(Address of principal executive offices)             (Zip Code)

 

Registrant’s telephone number, including area code     (404) 728-2000

 

None

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 


 


ITEM 8.01 Other Events.

 

NDCHealth Corporation (NYSE: NDC) was notified by the Atlanta District Office of the Securities and Exchange Commission that the previously disclosed informal inquiry has been converted to a formal investigation.

 

NDCHealth has cooperated fully with the informal inquiry and intends to continue to cooperate fully with the formal investigation.

 

The information in this Current Report on Form 8-K is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated into future filings under the Securities Act of 1933, as amended, or under the Securities Exchange Act of 1934, as amended unless expressly set forth in such future filing that such information is to be considered “filed” or incorporated by reference therein.

 

1


SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

NDCHealth Corporation

(Registrant)

By:   /s/ James W. FitzGibbons

James W. FitzGibbons

Vice President and Chief Accounting Officer

 

 

Date: January 12, 2005

 

2